Your session is about to expire
← Back to Search
Smoke Management System
Airseal® iFS for Laparoscopic Cholecystectomy
N/A
Waitlist Available
Research Sponsored by Alesi Surgical Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured from the exposure and identification of the cystic duct and artery is complete to the last use of diathermy
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the Ultravision™ System to the Airseal® iFS in people undergoing laparoscopic cholecystectomy (gallbladder removal).
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured from veress needle insertion to just prior to gall bladder removal
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured from veress needle insertion to just prior to gall bladder removal
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Carbon Dioxide Utilization
Quality of Visualization
Secondary study objectives
Case Complexity
Diathermy Power Setting
End tidal CO2 Volume
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Airseal® iFSActive Control1 Intervention
Smoke management during laparoscopic cholecsystectomy performed with the Airseal® iFS
Group II: Ultravision™ SystemActive Control1 Intervention
Smoke management during laparoscopic cholecystectomy performed with the Ultravision™ System
Find a Location
Who is running the clinical trial?
Alesi Surgical Ltd.Lead Sponsor
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger